[go: up one dir, main page]

DE69711779D1 - Neue Melatonin-Derivaten als Wirkstoff gegen freien Radikale sowie diese enthaltende Präparate - Google Patents

Neue Melatonin-Derivaten als Wirkstoff gegen freien Radikale sowie diese enthaltende Präparate

Info

Publication number
DE69711779D1
DE69711779D1 DE69711779T DE69711779T DE69711779D1 DE 69711779 D1 DE69711779 D1 DE 69711779D1 DE 69711779 T DE69711779 T DE 69711779T DE 69711779 T DE69711779 T DE 69711779T DE 69711779 D1 DE69711779 D1 DE 69711779D1
Authority
DE
Germany
Prior art keywords
active ingredient
free radicals
preparations containing
against free
ingredient against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69711779T
Other languages
English (en)
Other versions
DE69711779T2 (de
Inventor
Jean-Francois Nadaud
Christian Colin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69711779(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE69711779D1 publication Critical patent/DE69711779D1/de
Application granted granted Critical
Publication of DE69711779T2 publication Critical patent/DE69711779T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DE69711779T 1996-07-25 1997-07-18 Neue Melatonin-Derivaten als Wirkstoff gegen freien Radikale sowie diese enthaltende Präparate Revoked DE69711779T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609389A FR2751536B1 (fr) 1996-07-25 1996-07-25 Nouveaux derives de le melatonine anti-radicaux libres et compositions les comprenant

Publications (2)

Publication Number Publication Date
DE69711779D1 true DE69711779D1 (de) 2002-05-16
DE69711779T2 DE69711779T2 (de) 2002-08-14

Family

ID=9494487

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69711779T Revoked DE69711779T2 (de) 1996-07-25 1997-07-18 Neue Melatonin-Derivaten als Wirkstoff gegen freien Radikale sowie diese enthaltende Präparate

Country Status (7)

Country Link
US (1) US6093409A (de)
EP (1) EP0820768B1 (de)
JP (1) JP2991680B2 (de)
CA (1) CA2210675C (de)
DE (1) DE69711779T2 (de)
ES (1) ES2175297T3 (de)
FR (1) FR2751536B1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122758A (ja) * 1999-10-22 2001-05-08 Pola Chem Ind Inc ＡＧＥｓ分解作用を有する老化肌防御、改善化粧料
JP2002047182A (ja) * 2000-08-02 2002-02-12 Ito Keiko ペット用体毛品質改善外用組成物
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
FR2882595B1 (fr) * 2005-02-25 2007-05-25 Oreal Procede pour evaluer le potentiel de desactivation de radicaux libres de la peau
US8084268B2 (en) * 2005-02-25 2011-12-27 L'oreal Method of evaluating the potential of the skin for scavenging free radicals
EP2196190A1 (de) * 2008-12-09 2010-06-16 Cognis IP Management GmbH Hautbleichung
EP2694045B1 (de) 2011-04-01 2019-10-30 Iasomai AB Neue kombination mit n-acetyl-l-cystein und ihre verwendung
JP6403979B2 (ja) * 2014-04-28 2018-10-10 株式会社ミルボン カルボニル化度の評価方法
FR3065225B1 (fr) 2017-04-12 2024-04-05 Patrick Choay Sas Adjuvants depourvus de cytokines pour milieux de culture cellulaire, notamment pour fecondation in vitro, ou pour la culture de follicules, cellules germinales males ou embryons

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
JPH0778007B2 (ja) * 1985-03-04 1995-08-23 セレ−ナ （セル・エンジニアリング） ア−・ゲ− メラトニン組成物とその使用
US5560917A (en) * 1995-02-01 1996-10-01 Maybelline Intermediate Company Cosmetic makeup composition
WO1997006779A1 (en) * 1995-08-11 1997-02-27 Kistler Gonzague S Protection from ultraviolet (uv) radiation-induced skin damage by topical treatment with melatonin (n-acetyl-5-metroxytryptamine)

Also Published As

Publication number Publication date
EP0820768B1 (de) 2002-04-10
JPH1072339A (ja) 1998-03-17
CA2210675C (fr) 2003-03-11
FR2751536A1 (fr) 1998-01-30
CA2210675A1 (fr) 1998-01-25
US6093409A (en) 2000-07-25
JP2991680B2 (ja) 1999-12-20
EP0820768A2 (de) 1998-01-28
EP0820768A3 (de) 1998-02-04
DE69711779T2 (de) 2002-08-14
FR2751536B1 (fr) 1998-11-06
ES2175297T3 (es) 2002-11-16

Similar Documents

Publication Publication Date Title
DE69322076D1 (de) S-triazin-derivate und diese als aktiven wirkstoff enthaltende heilmittel gegen östrogen abhängige krankheiten
DE69415157D1 (de) Elektrochirurgischer prozessor und anwendung
DE69609353D1 (de) In der therapie verwendbare chinolin- und chinazolinverbindungen
ATE288419T1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
DE69815833D1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
DE69608414D1 (de) Als insektizid aktive zusammensetzung
DE59708905D1 (de) Injektionsformulierungen von avermectinen und milbemycinen
DE69714504D1 (de) Benzothiopene, diese enthaltende Zubereitungen und Verfahren
FR2769915B1 (fr) Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
NO965102D0 (no) Bicykliske aromatiske forbindelser, anvendelser derav, og farmasöytiske og kosmetiske preparater
DE69524871D1 (de) Benzopyrans und deren verwendung als therapeutische mittel
DE69611783D1 (de) Benzisoxazol- und indazol- derivate als antipsychotika
DE59610836D1 (de) Mittel gegen parasitäre protozoen
DE69711779D1 (de) Neue Melatonin-Derivaten als Wirkstoff gegen freien Radikale sowie diese enthaltende Präparate
DE69519368D1 (de) Neue antiandrogenen mitteln pharmazeutische präparate und verwendungen davon
DE4494713T1 (de) Arylsulfonamidderivate und diese Derivate enthaltende Arzneimittel
ATE273010T1 (de) Dermatologische anwendung von vitamin d derivate
ATE237934T1 (de) Insektizide und mitizide zusammensetzungen
ATE270272T1 (de) C11-oxymyl- and hydroxylamino-prostaglandine und ihre anwendung als arzneimittel
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
DE69710333D1 (de) Cyclopentan(en)säure-2-alkenyl-derivate als therapeutika in der behandlung der okulären hypertonie
DE4494231T1 (de) Therapeutische Zusammensetzung und ihre Anwendung
ATE204255T1 (de) Carbostyrilderivate als antithrombotische mittel

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation